231 related articles for article (PubMed ID: 23320987)
21. Tissue factor-expressing tumor cells can bind to immobilized recombinant tissue factor pathway inhibitor under static and shear conditions in vitro.
Che SP; DeLeonardis C; Shuler ML; Stokol T
PLoS One; 2015; 10(4):e0123717. PubMed ID: 25849335
[TBL] [Abstract][Full Text] [Related]
22. Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors.
Kopp CW; Siegel JB; Hancock WW; Anrather J; Winkler H; Geczy CL; Kaczmarek E; Bach FH; Robson SC
Transplantation; 1997 Mar; 63(5):749-58. PubMed ID: 9075849
[TBL] [Abstract][Full Text] [Related]
23. Translation of human tissue factor pathway inhibitor-β mRNA is controlled by alternative splicing within the 5' untranslated region.
Ellery PE; Maroney SA; Martinez ND; Wickens MP; Mast AE
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):187-95. PubMed ID: 24233486
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces.
Hamamoto T; Yamamoto M; Nordfang O; Petersen JG; Foster DC; Kisiel W
J Biol Chem; 1993 Apr; 268(12):8704-10. PubMed ID: 8473315
[TBL] [Abstract][Full Text] [Related]
25. Tissue factor pathway inhibitor: structure-function.
Broze GJ; Girard TJ
Front Biosci (Landmark Ed); 2012 Jan; 17(1):262-80. PubMed ID: 22201743
[TBL] [Abstract][Full Text] [Related]
26. Alternatively spliced isoforms of tissue factor pathway inhibitor.
Maroney SA; Ellery PE; Mast AE
Thromb Res; 2010 Apr; 125 Suppl 1():S52-6. PubMed ID: 20176395
[TBL] [Abstract][Full Text] [Related]
27. Catabolism of factor VIIa bound to tissue factor in fibroblasts in the presence and absence of tissue factor pathway inhibitor.
Iakhiaev A; Pendurthi UR; Voigt J; Ezban M; Vijaya Mohan Rao L
J Biol Chem; 1999 Dec; 274(52):36995-7003. PubMed ID: 10601255
[TBL] [Abstract][Full Text] [Related]
28. New insights into the biology of tissue factor pathway inhibitor.
Maroney SA; Mast AE
J Thromb Haemost; 2015 Jun; 13 Suppl 1(0 1):S200-7. PubMed ID: 26149025
[TBL] [Abstract][Full Text] [Related]
29. Tissue Factor Pathway Inhibitor: Multiple Anticoagulant Activities for a Single Protein.
Mast AE
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):9-14. PubMed ID: 26603155
[TBL] [Abstract][Full Text] [Related]
30. Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy.
Mast AE; Ruf W
J Thromb Haemost; 2022 Jun; 20(6):1290-1300. PubMed ID: 35279938
[TBL] [Abstract][Full Text] [Related]
31. Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface.
Ghosh S; Ezban M; Persson E; Pendurthi U; Hedner U; Rao LV
J Thromb Haemost; 2007 Feb; 5(2):336-46. PubMed ID: 17092304
[TBL] [Abstract][Full Text] [Related]
32. TFPI alpha and beta regulate mRNAs and microRNAs involved in cancer biology and in the immune system in breast cancer cells.
Stavik B; Skretting G; Olstad OK; Sletten M; Dehli Vigeland M; Sandset PM; Iversen N
PLoS One; 2012; 7(10):e47184. PubMed ID: 23071754
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of TFPI in human carotid stenosis.
Stavik B; Holm S; Espada S; Iversen N; Sporsheim B; Bjerkeli V; Dahl TB; Sandset PM; Skjelland M; Espevik T; Skretting G; Halvorsen B
Thromb Res; 2017 Jul; 155():31-37. PubMed ID: 28482260
[TBL] [Abstract][Full Text] [Related]
34. Progesterone utilizes distinct membrane pools of tissue factor to increase coagulation and invasion and these effects are inhibited by TFPI.
Henriquez S; Calderon C; Quezada M; Oliva B; Bravo ML; Aranda E; Kato S; Cuello MA; Gutiérrez J; Quest AF; Owen GI
J Cell Physiol; 2011 Dec; 226(12):3278-85. PubMed ID: 21344386
[TBL] [Abstract][Full Text] [Related]
35. Simvastatin induces apoptosis in human breast cancer cells in a NFkappaB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa.
Aberg M; Wickström M; Siegbahn A
Thromb Res; 2008; 122(2):191-202. PubMed ID: 18031796
[TBL] [Abstract][Full Text] [Related]
36. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.
Rao LV; Ruf W
Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667
[TBL] [Abstract][Full Text] [Related]
37. Reversible regulation of tissue factor-induced coagulation by glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor.
Ott I; Miyagi Y; Miyazaki K; Heeb MJ; Mueller BM; Rao LV; Ruf W
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):874-82. PubMed ID: 10712416
[TBL] [Abstract][Full Text] [Related]
38. Caveolin-1 enhances tissue factor pathway inhibitor exposure and function on the cell surface.
Lupu C; Hu X; Lupu F
J Biol Chem; 2005 Jun; 280(23):22308-17. PubMed ID: 15817451
[TBL] [Abstract][Full Text] [Related]
39. Factor Xa and VIIa inhibition by tissue factor pathway inhibitor is prevented by a monoclonal antibody to its Kunitz-1 domain.
Augustsson C; Svensson A; Kjaer B; Chao TY; Wenjuan X; Krogh BO; Breinholt J; Clausen JT; Hilden I; Petersen HH; Petersen LC
J Thromb Haemost; 2018 May; 16(5):893-904. PubMed ID: 29532595
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of antithrombin III inhibition of factor VIIa/tissue factor activity on cell surfaces. Comparison with tissue factor pathway inhibitor/factor Xa-induced inhibition of factor VIIa/tissue factor activity.
Rao LV; Nordfang O; Hoang AD; Pendurthi UR
Blood; 1995 Jan; 85(1):121-9. PubMed ID: 7803789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]